Literature DB >> 16136476

Coartem (artemether-lumefantrine) in Africa: the beginning of the end?

Ian M Hastings, Stephen A Ward.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16136476     DOI: 10.1086/432554

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  36 in total

1.  Reply to "no robust evidence of lumefantrine resistance".

Authors:  Mateusz M Plucinski; Eldin Talundzic; Lindsay Morton; Pedro Rafael Dimbu; Aleixo Panzo Macaia; Filomeno Fortes; Ira Goldman; Naomi Lucchi; Gail Stennies; John R MacArthur; Venkatachalam Udhayakumar
Journal:  Antimicrob Agents Chemother       Date:  2015-09       Impact factor: 5.191

Review 2.  Resisting resistance: dealing with the irrepressible problem of malaria.

Authors:  Geoffrey Edwards; Giancarlo A Biagini
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

3.  Development, evaluation, and application of an in silico model for antimalarial drug treatment and failure.

Authors:  Katherine Winter; Ian M Hastings
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

4.  Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine.

Authors:  Nahla B Gadalla; Ishag Adam; Salah-Eldin Elzaki; Sahar Bashir; Izdihar Mukhtar; Mary Oguike; Amal Gadalla; Fathi Mansour; David Warhurst; Badria B El-Sayed; Colin J Sutherland
Journal:  Antimicrob Agents Chemother       Date:  2011-09-06       Impact factor: 5.191

5.  High prevalence of pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.

Authors:  Jian Li; Jiangtao Chen; Dongde Xie; Santiago-M Monte-Nguba; Juan Urbano Monsuy Eyi; Rocio Apicante Matesa; Maximo Miko Ondo Obono; Carlos Sala Ehapo; Liye Yang; Danjie Lu; Hui Yang; Hui-Tian Yang; Min Lin
Journal:  Pathog Glob Health       Date:  2014-10-27       Impact factor: 2.894

6.  Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.

Authors:  Olusola Ojurongbe; Segun I Oyedeji; Wellington A Oyibo; Adetola F Fagbenro-Beyioku; Jürgen F Kun
Journal:  Wien Klin Wochenschr       Date:  2010-11-12       Impact factor: 1.704

7.  Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.

Authors:  Ric N Price; Anne-Catrin Uhlemann; Michele van Vugt; Al Brockman; Robert Hutagalung; Shalini Nair; Denae Nash; Pratap Singhasivanon; Tim J C Anderson; Sanjeev Krishna; Nicholas J White; François Nosten
Journal:  Clin Infect Dis       Date:  2006-04-26       Impact factor: 9.079

8.  Artemisinin combination therapy for malaria: beyond good efficacy.

Authors:  Ric N Price; Nicholas M Douglas
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

9.  Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border.

Authors:  Chansuda Wongsrichanalai; Steven R Meshnick
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

10.  Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.

Authors:  D M Kiboi; B N Irungu; B Langat; S Wittlin; R Brun; J Chollet; O Abiodun; J K Nganga; V C S Nyambati; G M Rukunga; A Bell; A Nzila
Journal:  Exp Parasitol       Date:  2009-03-24       Impact factor: 2.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.